» Articles » PMID: 31953455

Anti-diabetic Activity of Crude Polysaccharide and Rhamnose-enriched Polysaccharide from G. Lithophila on Streptozotocin (STZ)-induced in Wistar Rats

Overview
Journal Sci Rep
Specialty Science
Date 2020 Jan 19
PMID 31953455
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

The aim of the present study was to elucidate the anti-diabetic effects of the crude polysaccharide and rhamnose-enriched polysaccharide derived from G. lithophila on streptozotocin (STZ)-induced diabetic Wistar rats. Treatment with crude polysaccharide and rhamnose-enriched polysaccharide showed increases in body weight and pancreatic insulin levels and a decrease in blood glucose levels compared with control diabetic rats. The blood concentrations of total cholesterol (TC), triglycerides (TGs), low-density lipoprotein (LDL) and very-low-density lipoprotein (VLDL) decreased, and high-density lipoprotein (HDL) increased both in the crude polysaccharide- and rhamnose-enriched polysaccharide-treated rats. Superoxide dismutase (SOD) and glutathione peroxidase (GPx) levels increased, and malondialdehyde (MDA) levels decreased in the livers, kidneys and pancreases of crude polysaccharide- and rhamnose-enriched polysaccharide-treated rats. Immunohistological examination further confirmed that restoration of the normal cellular size of the islets of Langerhans and the rebirth of β-cells were found to be greater in the body region than in the head and tail regions of the pancreas. The crude polysaccharide- and rhamnose-enriched polysaccharide-treated diabetic rats showed normal blood glucose levels and insulin production, and reversed cholesterol levels and enzymatic actions. Therefore, rhamnose-enriched polysaccharide from G. lithophila acts as a potent anti-diabetic agent to treat diabetes and can lead to the development of an alternative medicine for diabetes in the future.

Citing Articles

Evaluation of the anti-diabetic and anti-inflammatory potentials of curcumin nanoparticle in diabetic rat induced by streptozotocin.

Alrashdi B, Askar H, Germoush M, Fouda M, Abdel-Farid I, Massoud D Open Vet J. 2025; 14(12):3375-3387.

PMID: 39927337 PMC: 11799653. DOI: 10.5455/OVJ.2024.v14.i12.22.


Effect of cubebin against streptozotocin-induced diabetic nephropathy rats via inhibition TNF-α/NF-κB/TGF-β: in vivo and in silico study.

Syed R, Moni S, Hussein W, Alhaidan T, Abumilha S, Alnahdi L Sci Rep. 2025; 15(1):4369.

PMID: 39910087 PMC: 11799316. DOI: 10.1038/s41598-025-87319-7.


The effect of hydrophilic statins on adiponectin, leptin, visfatin, and vaspin levels in streptozocin-induced diabetic rats.

Kaya H, Demirtas B Naunyn Schmiedebergs Arch Pharmacol. 2024; .

PMID: 39382680 DOI: 10.1007/s00210-024-03517-6.


Koidz. and Lam. extract relieves insulin resistance via PI3K/Akt signalling in diabetic .

Li Y, Xu Y, Zhang B, Wang Z, Ma L, Sun L J Tradit Complement Med. 2024; 14(4):424-434.

PMID: 39035690 PMC: 11259714. DOI: 10.1016/j.jtcme.2024.01.010.


Mediated Digestion of Water-Soluble Polysaccharides from Cress Seed Mucilage Produces Potent Antidiabetic Oligosaccharides.

Khan I, Jamil Y, Khan A, Ahmad J, Iqbal A, Ali S Pharmaceuticals (Basel). 2024; 17(6).

PMID: 38931372 PMC: 11206588. DOI: 10.3390/ph17060704.


References
1.
El-Atat F, McFarlane S, Sowers J . Diabetes, hypertension, and cardiovascular derangements: pathophysiology and management. Curr Hypertens Rep. 2004; 6(3):215-23. DOI: 10.1007/s11906-004-0072-y. View

2.
Wild S, Roglic G, Green A, Sicree R, King H . Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004; 27(5):1047-53. DOI: 10.2337/diacare.27.5.1047. View

3.
Chan J, Malik V, Jia W, Kadowaki T, Yajnik C, Yoon K . Diabetes in Asia: epidemiology, risk factors, and pathophysiology. JAMA. 2009; 301(20):2129-40. DOI: 10.1001/jama.2009.726. View

4.
Shaw J, Sicree R, Zimmet P . Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract. 2009; 87(1):4-14. DOI: 10.1016/j.diabres.2009.10.007. View

5.
King H, Aubert R, Herman W . Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care. 1998; 21(9):1414-31. DOI: 10.2337/diacare.21.9.1414. View